A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS

NCT03290131 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
536
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

RVL Pharmaceuticals, Inc.

Collaborators